Form 8-K - Current report:
SEC Accession No. 0001140361-21-027961
Filing Date
2021-08-12
Accepted
2021-08-11 18:08:59
Documents
16
Period of Report
2021-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10027960_8k.htm   iXBRL 8-K 31261
2 EXHIBIT 99.1 brhc10027960_ex99-1.htm EX-99.1 31769
3 EXHIBIT 99.2 brhc10027960_ex99-2.htm EX-99.2 15944
8 image00001.jpg GRAPHIC 6107
  Complete submission text file 0001140361-21-027961.txt   279713

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20210809.xsd EX-101.SCH 4377
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20210809_def.xml EX-101.DEF 17551
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20210809_lab.xml EX-101.LAB 27040
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20210809_pre.xml EX-101.PRE 19730
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027960_8k_htm.xml XML 6009
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 211164915
SIC: 2836 Biological Products, (No Diagnostic Substances)